Inactive
Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)
Notice ID:36C25022Q0986
Statement of Work Chartis Medicine Service Pulmonary 7/28/2022 The Chartis system can provides real time flow measurement -based recording of collateral ventilation which can correctly identify Zephyr...
Statement of Work Chartis Medicine Service Pulmonary 7/28/2022 The Chartis system can provides real time flow measurement -based recording of collateral ventilation which can correctly identify Zephyr valve responders in approximately 90% of the cases. The Zephyr valve is the only one that is FDA approved to potentially reduce lung the number of reduction surgeries Using the Zephyr can help reduce respiratory tract infections and COPD exacerbations. This can drastically increase quality of a patient's life